https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
70; women, AOR = 0.65; 95%CI0.46-0.91), in individuals over or under 70 years of age (AOR = 0.54; 95%CI0.38-0.77, and AOR = 0.61; 95%CI0.45-0.82, respectively) and in individuals at intermediate (AOR = 0.65; 95%CI0.48-0.91) and high cardiovascular risk (AOR = 0.48; 95%CI0.27-0.83), but not in those at low risk (AOR = 1.11; 95%CI0.48-2.56). In contrast, the current use of glucosamine was not associated with either increased or decreased risk of AMI (AOR = 0.86; 95%CI0.66-1.08). Our results support a cardioprotective eff
Like
Comment
Share
